Teleflex Long Term Debt 2010-2022 | TFX

Teleflex long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
  • Teleflex long term debt for the quarter ending September 30, 2022 was $1.594B, a 18.23% decline year-over-year.
  • Teleflex long term debt for 2021 was $1.74B, a 26.82% decline from 2020.
  • Teleflex long term debt for 2020 was $2.378B, a 27.92% increase from 2019.
  • Teleflex long term debt for 2019 was $1.859B, a 10.29% decline from 2018.
Teleflex Annual Long Term Debt
(Millions of US $)
2021 $1,740
2020 $2,378
2019 $1,859
2018 $2,072
2017 $2,163
2016 $852
2015 $642
2014 $700
2013 $930
2012 $965
2011 $955
2010 $813
2009 $1,192
Teleflex Quarterly Long Term Debt
(Millions of US $)
2022-09-30 $1,594
2022-06-30 $1,606
2022-03-31 $1,741
2021-12-31 $1,740
2021-09-30 $1,949
2021-06-30 $2,216
2021-03-31 $2,295
2020-12-31 $2,378
2020-09-30 $2,036
2020-06-30 $2,329
2020-03-31 $2,341
2019-12-31 $1,859
2019-09-30 $1,949
2019-06-30 $2,081
2019-03-31 $2,073
2018-12-31 $2,072
2018-09-30 $2,076
2018-06-30 $2,145
2018-03-31 $2,154
2017-12-31 $2,163
2017-09-30 $2,173
2017-06-30 $1,888
2017-03-31 $1,958
2016-12-31 $852
2016-09-30 $850
2016-06-30 $908
2016-03-31 $655
2015-12-31 $642
2015-09-30 $646
2015-06-30 $696
2015-03-31 $700
2014-12-31 $700
2014-09-30 $700
2014-06-30 $700
2014-03-31 $930
2013-12-31 $930
2013-09-30 $981
2013-06-30 $971
2013-03-31 $968
2012-12-31 $965
2012-09-30 $963
2012-06-30 $960
2012-03-31 $957
2011-12-31 $955
2011-09-30 $952
2011-06-30 $950
2011-03-31 $822
2010-12-31 $813
2010-09-30 $904
2010-06-30 $1,128
2010-03-31 $1,141
2009-12-31 $1,192
2009-09-30 $1,249
2009-06-30 $1,300
2009-03-31 $1,300
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.124B $2.810B
Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $230.517B 25.29
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00